Brief: Twist Bioscience And Centogene To Develop Advanced Sequencing Tools To Make Genetic Testing Rapidly Accessible For More Patients With Rare Diseases
Oct 6 (Reuters) - Twist Bioscience Corp TWST.O :
* TWIST BIOSCIENCE AND CENTOGENE TO DEVELOP ADVANCED
SEQUENCING
TOOLS TO MAKE GENETIC TESTING RAPIDLY ACCESSIBLE FOR MORE
PATIENTS WITH RARE DISEASES
* TWIST BIOSCIENCE CORP - FINANCIAL DETAILS WERE NOT
DISCLOSED
Source text for Eikon: ID:nBw9NKf9Ga
Further company coverage: TWST.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crown LiquidationCo NV in liquidatie
See all newsBrief: Centogene Signs Strategic Transaction With Private Equity Group Charme Capital Partners
Brief: Centogene Announces Adoption Of All Resolutions Tabled At 2024 Annual General Meeting
Brief: Centogene NV Says Agreements With LIFERA Provides Funding In Aggregate Of About $20 Mln To Co
Brief: Centogene And Evotec Discover Promising New Molecule To Treat Gaucher Disease
Brief: Centogene Receives Nasdaq Non-Compliance Notice